# Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse

> **NCT00809835** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 120 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **DRUG:** Galantamine
- **BEHAVIORAL:** Computer Assisted Cognitive Behavioral Therapy (CBT)

## Key facts

- **NCT ID:** NCT00809835
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2019-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00809835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00809835, "Galantamine to Enhance Cognitive Behavioral Therapy for Cocaine Abuse". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00809835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*